低用量のヘパリン

Same author

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Same author

Within-guild dietary discrimination from 3-D textural analysis of tooth microwear in insectivorous mammals.

Journal of zoology (London, England : 1987)·2015

Same author

Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases.

British journal of cancer·2011

Same author

Surgical approach to insulinomas: are pre-operative localisation tests necessary?

Annals of the Royal College of Surgeons of England·2007

Same author

Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer.

Breast (Edinburgh, Scotland)·2006

Same author

Sentinel node biopsy in breast cancer--the view from Australia and New Zealand.

Breast (Edinburgh, Scotland)·2004

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

低用量のヘパリン

関連する概念動画

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.

Within-guild dietary discrimination from 3-D textural analysis of tooth microwear in insectivorous mammals.

Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases.

Surgical approach to insulinomas: are pre-operative localisation tests necessary?

Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer.

Sentinel node biopsy in breast cancer--the view from Australia and New Zealand.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

低用量のヘパリン

関連する概念動画

関連記事

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.

Within-guild dietary discrimination from 3-D textural analysis of tooth microwear in insectivorous mammals.

Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases.

Surgical approach to insulinomas: are pre-operative localisation tests necessary?

Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer.

Sentinel node biopsy in breast cancer--the view from Australia and New Zealand.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.